There's been yet another shakeup of leadership at the NIH -- this time, a division director has resigned after a seasonal flu ...

Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...

Results from a Phase 1 study of GT-02287 in healthy volunteers demonstrated favorable safety and tolerability, plasma and CNS exposures in the projected therapeutic range, and target engagement with ...

Potential Risks and Benefits of Gain-of-Function Research is the summary of a two-day public symposium on Gain of Function (GOF) research. Convened in December 2014 by the National Research Council ...

Former CDC Director Robert Redfield exposes the mistakes of COVID-19 and prepares us for the future. Dr. Robert Redfield ...

This comprehensive review synthesizes a decade of human and animal research to explain how the gut and brain communicate ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ('Gain”, or the 'Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...

GRIN Therapeutics begins patient dosing in global phase 3 Beeline trial of investigational radiprodil for GRINRelated neurodevelopmental disorder: New York Monday, January 12, 202 ...

Research shows many benefits in the use of creatine supplements in women. Experts explain how to use creatine, what creatine ...

The American Academy of Pediatrics has joined the ranks of organizations that are losing funding for grants that, federal officials say, don’t align with the Trump administration’s missions or ...

After greenlighting 56 novel therapeutics in 2025, four notable applications continue to await the agency’s action after ...

A new study finds that even after weight returns in anorexia nervosa, muscle strength may remain impaired, with implications ...